Molecular Templates (NASDAQ: MTEM)
$1.48
(-6.0%)
-$0.10
Price as of April 18, 2024, 3:59 p.m. ET
Molecular Templates Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Molecular Templates Company Info
Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean Gariépy, and Leigh Revers in 2000 and is headquartered in Austin, TX.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.